• infectious diseases
  • cancer
  • metabolic disorders
  • rare genetic disorders
  • business strategy
  • about us
  • product pipeline
  • science
  • partners
  • patients
  • investors
  • newsroom
  • careers
  • our company
  • our people
  • contact us
  • product pipeline
  • drug candidates
  • LNA drug platform
  • drug discovery engine
  • mechanism of action
  • intellectual property
  • scientific publications
  • partners & collaborators
  • clinical trials & resources
  • investors
  • corporate governance
  • news releases
  • media kit
  • events

   contact us

  • management
  • the board
Santaris Pharma A/S has a robust pipeline of RNA-targeted drugs for a range of diseases including infectious and inflammatory diseases, cancer, metabolic disorders and rare genetic disorders

media kit

Corporate Fact Sheet 

Miravirsen (SPC3649) Product Backgrounder

LNA Drug Platform and Drug Discovery Engine Backgrounder

Product Pipeline Therapeutic Area Fact Sheet 

Partners and Collaborations Fact Sheet 

Glossary of Terms

download logo

 
Copyright © 2010, 2011 Santaris Pharma A/S | Terms & Conditions | Privacy Policy | Site Map | Home
DESIGNED BY MENTUS